Brookline Capital Acquisition Corp (BCAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAC | AZN | AMGN | GILD | BMY |
| Company | Brookline Capital Acquisition Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.07 | 201.44 | 346.63 | 138.61 | 57.67 |
| High | 27.74 | 201.80 | 351.25 | 140.27 | 58.67 |
| Low | 9.94 | 200.79 | 346.63 | 138.61 | 57.66 |
| Latest | 22.71 | 200.67 | 350.18 | 139.39 | 58.25 |
| Change | +12.63 | -0.54 | +1.96 | -0.38 | +0.36 |
| % Change | +125.30% | -0.27% | +0.56% | -0.27% | +0.62% |
| Volume | 586,400 | 258,090 | 155,306 | 304,229 | 632,175 |
| 20-Day Average Volume | 69,480 | 1,861,943 | 2,646,019 | 5,730,503 | 12,490,171 |
| Previous Close | 10.08 | 201.21 | 348.22 | 139.77 | 57.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.81 | 196.11 | 349.56 | 138.95 | 58.76 |
| 20-Day Raw Stochastic | 72.42% | 74.07% | 58.60% | 60.19% | 31.52% |
| 20-Day Relative Strength | 93.64 | 54.59 | 46.31 | 47.66 | 47.92 |
| Weighted Alpha | +26.80 | +47.02 | +24.94 | +32.40 | +22.85 |
| Today's Opinion | 100% Buy | 88% Buy | 40% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 40% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +130.09% since 07/22/22 | -2.02% since 04/09/26 | -1.76% since 04/09/26 | -1.92% since 04/09/26 | -2.02% since 04/09/26 |
| Low | 9.68 on 07/25/22 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 137.02 on 04/13/26 | 57.22 on 04/15/26 |
| High | 27.74 on 07/29/22 | 207.30 on 04/10/26 | 357.46 on 04/10/26 | 142.38 on 04/10/26 | 59.80 on 04/10/26 |
| 1-Month | |||||
| %Chg | +123.52% since 06/29/22 | +4.60% since 03/16/26 | -4.61% since 03/16/26 | -4.03% since 03/16/26 | -2.41% since 03/16/26 |
| Low | 9.50 on 07/22/22 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 27.74 on 07/29/22 | 207.30 on 04/10/26 | 368.78 on 03/17/26 | 146.71 on 03/17/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +124.52% since 04/29/22 | +6.39% since 01/16/26 | +5.73% since 01/16/26 | +11.56% since 01/16/26 | +5.45% since 01/16/26 |
| Low | 9.50 on 07/22/22 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 53.54 on 01/21/26 |
| High | 27.74 on 07/29/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +127.10% since 01/28/22 | +19.79% since 10/16/25 | +18.10% since 10/16/25 | +18.25% since 10/16/25 | +34.29% since 10/16/25 |
| Low | 9.50 on 07/22/22 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 27.74 on 07/29/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 153,204 | 312,058,208 | 187,929,120 | 173,485,616 | 118,196,040 |
| Shares Outstanding, K | 6,746 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,457,658 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -0.03 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/23/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/01/70 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.31 | 16.06 | 17.23 | 9.44 |